Literature DB >> 31535542

Historical evolution of the diseases caused by non-pigmented rapidly growing mycobacteria in a University Hospital.

M Garcia-Coca, G Rodriguez-Sevilla, M C Muñoz-Egea, C Perez-Jorge, N Carrasco-Anton, J Esteban1.   

Abstract

OBJECTIVE: Non-pigmented rapidly growing mycobacteria (NPRGM) are a group of organisms of increasing interest due to the growing number of potential patients and the difficulties for a proper treatment in many of them. However, the evolution of these diseases in a long period of time and its evolutionary changes has been described only in a scanty number of reports.
METHODS: We performed a retrospective study between January 1st 2004 and December 31st 2017 in order to evaluate the clinical significance and types of diseases caused by NPRGM. Patients with isolates of NPRGM during this period were selected for the study, and clinical charts were reviewed using a predefined protocol.
RESULTS: During this period we identified 59 patients (76 clinical samples) with isolates of NPRGM, with 12 cases of clinical disease and one patient with doubtful significance (including 6 respiratory tract infections, 2 catheter infections, 1 skin and soft tissue infection, 1 disseminated infection, 1 conjunctivitis, 1 prosthetic joint infection and 1 mastitis). Fifty percent of M. chelonae isolates, 37.5% of M. abscessus isolates and 23.33% of M. fortuitum isolates were clinically significant. None of the isolates of other species were significant.
CONCLUSIONS: Most isolates in respiratory samples were contaminants/colonizations. M. abscessus was the main etiological agent in respiratory syndromes, whereas M. chelonae and M. fortuitum were more frequently associated with other infections, especially clinical devices and skin and soft tissue infections. ©The Author 2019. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Entities:  

Mesh:

Year:  2019        PMID: 31535542      PMCID: PMC6790884     

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


  38 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Wound infections due to Mycobacterium fortuitum after polypropylene mesh inguinal hernia repair.

Authors:  A Celdrán; J Esteban; J Mañas; J-J Granizo
Journal:  J Hosp Infect       Date:  2007-07-25       Impact factor: 3.926

Review 3.  Mycobacteria in drinking water distribution systems: ecology and significance for human health.

Authors:  Mario J M Vaerewijck; Geert Huys; Juan Carlos Palomino; Jean Swings; Françoise Portaels
Journal:  FEMS Microbiol Rev       Date:  2005-02-19       Impact factor: 16.408

Review 4.  Nontuberculous mycobacteria in the environment.

Authors:  Joseph O Falkinham
Journal:  Clin Chest Med       Date:  2002-09       Impact factor: 2.878

5.  Large joint osteoarticular infection caused by Mycobacterium arupense.

Authors:  Adam Seidl; Bennie Lindeque
Journal:  Orthopedics       Date:  2014-09       Impact factor: 1.390

6.  Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies.

Authors:  Barbara A Brown-Elliott; Richard J Wallace; Carmen Tichindelean; Juan C Sarria; Steven McNulty; Ravikaran Vasireddy; Linda Bridge; C Glenn Mayhall; Christine Turenne; Michael Loeffelholz
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

7.  Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections.

Authors:  Leonard J Lobo; Lydia C Chang; Charles R Esther; Peter H Gilligan; Zeynep Tulu; Peadar G Noone
Journal:  Clin Transplant       Date:  2013-05-26       Impact factor: 2.863

Review 8.  Mycobacterium mucogenicum group infections: a review.

Authors:  T Adékambi
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

9.  Bacteremia caused by Mycobacterium wolinskyi.

Authors:  Yu-Chuan Chen; Ruwen Jou; Wei-Lun Huang; Shao-Tsung Huang; Keng-Chang Liu; Chorng-Jang Lay; Shu-Mei Chang; Chih-En Tseng; Chun-Liang Lai; Yu-Chieh Su
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

10.  US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary.

Authors:  R Andres Floto; Kenneth N Olivier; Lisa Saiman; Charles L Daley; Jean-Louis Herrmann; Jerry A Nick; Peadar G Noone; Diana Bilton; Paul Corris; Ronald L Gibson; Sarah E Hempstead; Karsten Koetz; Kathryn A Sabadosa; Isabelle Sermet-Gaudelus; Alan R Smyth; Jakko van Ingen; Richard J Wallace; Kevin L Winthrop; Bruce C Marshall; Charles S Haworth
Journal:  Thorax       Date:  2016-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.